Dr. Bolton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Hospital Dr
# Hospital
Charlottesville, VA 22908Phone+1 434-924-1984Fax+1 434-924-5898
Education & Training
- University of ChicagoResidency, Internal Medicine, 1971 - 1973
- Boston City Hospital - Harvard II & IV Service1969 - 1971
- University of Virginia School of MedicineClass of 1969
Certifications & Licensure
- VA State Medical License 1969 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
- Elected Member The American Society for Clinical Investigation, 1985
Clinical Trials
- Abdominal Compression Elastic Support (ACES) Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 41 citationsEpitope Spreading and Autoimmune Glomerulonephritis in Rats Induced by a T Cell Epitope of Goodpasture’s AntigenWarren K. Bolton, Lanlin Chen, Thomas Hellmark, Jörgen Wieslander, Jay W. Fox
Journal of the American Society of Nephrology. 2005-09-01 - 75 citationsMethylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis.Kline Bolton, Benjamin C. Sturgill
American Journal of Nephrology. 1989-01-01 - 13 citationsOral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.Garland A. Campbell, James T. Patrie, Bruce D. Gaylinn, Michael O. Thorner, Warren K. Bolton
Nephrology, Dialysis, Transplantation. 2018-03-01
Grant Support
- Experimental Autoimmune Nephritis: Epitope Spreading In Pathogenesis And ControlNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Growth Hormone Secretagogue MK-677 Therapy Effect On IGF-1 Levels In CKD &EsrdNational Center For Research Resources2008–2009
- Growth Hormone Secretagogue MK-677 Therapy In CKD And ESRDNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Assessment Of Ghrelin Levels In END Stage Renal Disease (ESRD)National Center For Research Resources2006
- Assessment Of Ghrelin Levels In Chronic Kidney DiseaseNational Center For Research Resources2004–2005
- Donepezil Hydrochloride (ARICEPT) PharmacokineticsNational Center For Research Resources2000–2002
- Nephritogenic Epitopes In Goodpastures SyndromeNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2001
- Placebo Controlled Safety And Efficacy Of Aminoguanidine In Diabetic PatientsNational Center For Research Resources1995–2000
- Auriculin Anaritide In The Treatment Of Oliguric Acute Tubular NecrosisNational Center For Research Resources1997
- Cell Mediated Glomerulonephritis In A New ModelNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1994
- Dynamics Of Endogenous Gonadotropin Secretion In Renal FailureNational Center For Research Resources1991–1992
- Diabetic Kidney Study--Enalapril In Type II Diabetics With HypertensionNational Center For Research Resources1990–1992
- Diabetic Kidney Study--Enalapril In Diabetics With HypertensionNational Center For Research Resources1988–1989
- Study Of Experimental Autoimmune NephritisNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1988
- Cefoperazone And Sulbactam Therapy In END State Renal DiseaseNational Center For Research Resources1986
- Study Of Experimental Autoimmune In ChickensNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: